Greg Divis is the President and CEO of KV Pharmaceutical, a leading specialty pharmaceutical company dedicated to woman’s healthcare. Mr. Divis has been working in the pharmaceutical industry for more than 20 years and joined KV Pharmaceutical in the summer of 2007 as the President of Ther-Rx Corporation, the branded pharmaceutical subsidiary of the Company. He was named permanent CEO in November 2010 while continuing to serve as President of Ther-Rx Corporation.
Mr. Divis began his career as a sales representative and has served in a variety of commercial and general management leadership roles at pharmaceutical companies such as Schering-Plough Corporation and Sanofi-Aventis both in the US and in Europe. This included direct responsibility for entire country operations, extensive business development experience, and significant commercial leadership experience for large multi-national corporations. Mr. Divis earned a Bachelor’s degree from the University of Iowa.
